Journal
MOVEMENT DISORDERS
Volume 24, Issue 15, Pages 2175-2186Publisher
WILEY
DOI: 10.1002/mds.22589
Keywords
apathy; hallucinations; depression; anxiety; Parkinson's disease
Categories
Funding
- Novartis Pharmaceuticals
- GE Health
- Boehringer Ingelheim
- Osmotica Pharmaceuticals
Ask authors/readers for more resources
Neuropsychiatric symptoms are common in Parkinson's disease, even at the earliest stages. and have important consequences for quality of life and daily functioning, are associated with increased carer burden and increased risk for nursing home admission. In addition to cognitive impairment, a wide range of neuropsychiatric symptoms have been reported. In this article, the epidemiology, clinical course, disagnosis, and management of some of the most common neuropsychiatric symptoms in PD are discussed: depression, anxiety, apathy, fatigue, and psychotic symptoms. Although much is known regarding the prevalence and course of these symptoms, the empirical evidence for how to manage these symptoms is limited at best. There is thus an urgent need for systematic studies for the pharmacological and non-pharmacological management of these symptoms. (C) 2009 Movement Disorder Society
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available